Nassour reveals to LBCI why Febrectol and TROPHIRES were pulled from Lebanese market

Breaking Headlines
20-03-2012 | 08:20
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
Nassour reveals to LBCI why Febrectol and TROPHIRES were pulled from Lebanese market
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
0min
Nassour reveals to LBCI why Febrectol and TROPHIRES were pulled from Lebanese market
The Pharmacists’ Syndicate Chief Ziad Nassour explained on Tuesday that the decision to recall certain drugs from the market, such as Febrectol and TROPHIRES, and to ban their trading, is based on a study conducted in France in November 2011 that has proven that these drugs contain derivatives of Terpenes and may cause neurological disorders (including seizures) in children under 30 months old or those diagnosed with epilepsy.    

Nassour confirmed to Nharkom Said TV show that there are no counterfeit drugs in Lebanon, adding that he cannot guarantee dispensaries may not still have these drugs available to the public as they are not directly supervised by the syndicate.  

Breaking Headlines

reveals

Febrectol

TROPHIRES

pulled

Lebanese

market

LBCI Next
A patient at Notre Dame De Liban Hospital - Jounieh urgently needs A+ blood type, to donate please call: 70 281 616
Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More